Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F9MM7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,799
Award facts
- Contract value 100% obligated
- $27,798.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $27,798.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with performance in Conshohocken, Pennsylvania and completion targeted for January 23, 2026. This non-set-aside award was issued on January 22, 2026 and represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s comprehensive Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999 through December 2031. Repatha is a prescription medication used for managing high cholesterol and reducing cardiovascular risk in eligible patients, fulfilling critical pharmaceutical supply needs for military healthcare systems.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and healthcare solutions provider to federal military and veteran healthcare programs. The company competed on a full and open basis to secure this delivery order, demonstrating its capability to efficiently supply specialized pharmaceutical products across therapeutic domains. The broader DLA Troop Support Medical contract vehicle under which this order was issued enables comprehensive global pharmaceutical support to military treatment facilities and Defense Health Agency customers, encompassing brand-name and generic medications, vaccines, medical devices, and specialty healthcare commodities.
Quick answers
Who was awarded contract SPE2DR26F9MM7?
SPE2DR26F9MM7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F9MM7 worth?
The government has obligated $27,799 on SPE2DR26F9MM7.
Is contract SPE2DR26F9MM7 an order under another contract?
Yes. SPE2DR26F9MM7 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9MM7 competed?
The extent of competition for SPE2DR26F9MM7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award